Dataset Information


S100A6 expression and function in human osteosarcoma.

ABSTRACT: There is a critical need to identify markers that can accurately identify existing or predict future metastatic disease in patients with osteosarcoma since the majority of patients present with undetectable micrometastatic disease. We previously reported S100A6 is overexpressed in human osteosarcoma and increased expression of S100A6 by immunohistochemistry correlated with decreased clinical metastasis. We have established 11 primary cultures from biopsies of patients with osteosarcoma and ten of the 11 primary cultures have increased expression of S100A6 relative to normal human osteoblasts. To further explore possible mechanisms for metastasis suppression previously reported, we used in this report siRNA-mediated knockdown of S100A6 in four commonly used human osteosarcoma lines, then examined their cell adhesion, migration, and invasion properties. Knockdown of S100A6 expression inhibited cell adhesion and promoted cell migration and invasion in these lines. Conversely, S100A6 overexpression enhanced cell adhesion and inhibited cell invasion. Our data demonstrate S100A6 is commonly overexpressed in human osteosarcoma. S100A6 may inhibit osteosarcoma metastasis by promoting cell adhesion and inhibiting cell motility and invasion. Thus, S100A6 may be considered a potential marker for human osteosarcoma with prognostic value for identifying patients without metastases.

PROVIDER: S-EPMC2493010 | BioStudies | 2008-01-01

REPOSITORIES: biostudies

Similar Datasets

2010-01-01 | S-EPMC2913363 | BioStudies
2018-01-01 | S-EPMC6155331 | BioStudies
1000-01-01 | S-EPMC4116521 | BioStudies
1000-01-01 | S-EPMC5312406 | BioStudies
2017-01-01 | S-EPMC5865773 | BioStudies
1000-01-01 | S-EPMC5001879 | BioStudies
2020-01-01 | S-EPMC7313082 | BioStudies
2004-01-01 | S-EPMC2364790 | BioStudies
2015-01-01 | S-EPMC4466641 | BioStudies
2020-01-01 | S-EPMC7048933 | BioStudies